Study protocol for a randomized clinical trial evaluating the effectiveness of a Brazilian lifestyle-based diabetes prevention program: the PROVEN-DIA trial
Preprint
Abstract
Type 2 diabetes (T2D) affects more than 16 million Brazilians and has nearly doubled in the last 20 years. Lifestyle interventions reduce T2D incidence in people at risk of developing the disease; however, no large-scale trials have evaluated diabetes prevention programs in Brazil or compared telehealth and hybrid delivery in middle-income settings. These are key gaps that must be addressed to enable nationwide scale-up, particularly in primary care settings and remote areas. This article presents the protocol for the PROVEN-DIA trial, designed to address these evidence gaps. PROVEN-DIA is a multicenter, open-label, randomized controlled superiority trial with a parallel design enrolling 1,305 adults with prediabetes at 30 sites across all five Brazilian regions (ClinicalTrials.gov: NCT06426277 ). Participants will be randomly assigned in equal numbers to one of three groups. All groups receive lifestyle guidance targeting diet, physical activity, sleep, stress, alcohol consumption, and smoking, in accordance with Brazilian national guidelines. The two intervention groups receive PROVEN-DIA, a structured 36-month lifestyle program with 43 scheduled contacts encompassing individual counseling sessions, structured support contacts, and group education sessions, delivered either in a hybrid format (PROVEN-DIA) or telehealth only (TelePROVEN-DIA). The control group receives the same lifestyle guidance through unstructured individual visits every six months, without predefined content or ongoing support. The primary outcome is the cumulative incidence of type 2 diabetes at 36 months. Secondary outcomes include body weight, fasting glucose, glycated hemoglobin (HbA1c), dietary quality, physical activity, sedentary behavior, sleep quality, perceived stress, alcohol consumption, smoking behavior, and health-related quality of life. Analyses will follow the intention-to-treat principle.Keywords
This publication has 30 references indexed in Scilit:
- Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participantsThe Lancet, 2024
- Preferences for and use of oral anticoagulants for stroke prevention in atrial fibrillation under real-world conditions in Germany: A survey among physiciansPreventive Medicine Reports, 2022
- Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitusCochrane Database of Systematic Reviews, 2017
- Telehealth and patient satisfaction: a systematic review and narrative analysisBMJ Open, 2017
- Validation of the Brazilian Portuguese version of the Pittsburgh Sleep Quality IndexSleep Medicine, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia, 2006
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985